A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FC / fixed combination

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FC  (>> Co-occurring Abbreviation)
Long Form:   fixed combination
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: Asystematic review and meta-analysis. IOP, MD, OHT, POAG
2019 Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination. IOP, MOPP, OCTA, ONH, POAG, VD
2018 Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens. AEs, BBFC, IOP
2018 Measurement of the Retention Time of Different Ophthalmic Formulations with Ultrahigh-Resolution Optical Coherence Tomography. CTFT, OCT
2016 Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice. IOP, PF
2015 Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study. ARB, HR, MPR
2015 Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs. ER, HCT, HTN, MPR, PDC, PSM, SPC
2015 Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma. PF
2014 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components. AEs, CI, IOP, PF, PGA, PS, TIM, TS
10  2014 Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients. IOP, NFC, PP
11  2013 Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy. CIs, FDCs
12  2011 Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice. IOP
13  2011 From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch study. CI, GSS, IOP, IQR, SYMP, TFBUT
14  2011 [Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine]. BIA, NHS
15  2011 [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension]. CVE, SPC
16  2010 Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension. CI, IOP
17  2010 Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. ARB, CI, ER, IRR, MPR, SPC
18  2010 Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study. IOP, PP
19  2010 Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination. CI, IOP, ITT, OAG, OHT
20  2010 [Analysis of the budget impact for the Spanish National Health System of the fixed combination of amlodipine 5 or 10mg and atorvastatin 10mg]. BIA, CVEs, SNS
21  2009 Ophthalmologist attitudes regarding fixed combination treatment for glaucoma in the European Union. ---
22  2008 Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension. BIM, IOP, TIM
23  2008 Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy. FDC
24  2004 A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe. IOP, UFC
25  2004 An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension. IOP
26  2002 Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy. ---